ICD-10 Code C88.0 | Waldenstrom macroglobulinemia Symptoms, Diagnosis, Billing

Waldenstrom macroglobulinemia is a rare type of non-Hodgkin lymphoma characterized by the overproduction of IgM antibodies by malignant B cells. This condition can lead to various complications, including hyperviscosity syndrome, anemia, and organ dysfunction. Accurate coding with ICD-10 Code C88.0 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.

What is ICD-10 Code C88.0 for Waldenstrom macroglobulinemia?

ICD-10 Code C88.0 specifically represents Waldenstrom macroglobulinemia, a lymphoproliferative disorder associated with the proliferation of IgM-secreting B cells. This code should be used in clinical documentation and billing when diagnosing patients with this condition, particularly when symptoms such as fatigue, weight loss, and neurological issues are present, indicating the need for targeted treatment and management.

ICD-10 Code C88.0 – Clinical Definition and Explanation of Waldenstrom macroglobulinemia

Waldenstrom macroglobulinemia is caused by the malignant proliferation of B lymphocytes that produce excessive amounts of IgM antibodies. The condition can progress slowly, leading to significant morbidity if not addressed. Prompt medical attention is crucial to manage symptoms and prevent complications.

Key Clinical Features:

• Elevated serum IgM levels leading to hyperviscosity syndrome.
• Symptoms may include fatigue, weakness, and weight loss.
• Potential for anemia and thrombocytopenia.
• Neurological symptoms such as headaches or visual disturbances.

ICD-10 Code C88.0 for Waldenstrom macroglobulinemia – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code C88.0 is utilized to document the diagnosis of Waldenstrom macroglobulinemia, guiding the assessment of symptoms, treatment plans, and patient management strategies. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation.

What Does ICD-10 Code C88.0 for Waldenstrom macroglobulinemia Mean in SOAP Notes?

ICD-10 Code C88.0 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Waldenstrom macroglobulinemia. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C88.0 – Waldenstrom macroglobulinemia

Waldenstrom macroglobulinemia often requires hospitalization for management of complications. Treatment may include chemotherapy and targeted therapies.

Antibiotic Therapy:

• Not applicable as Waldenstrom macroglobulinemia is not an infectious disease.

Supportive Care:

• Plasmapheresis for hyperviscosity syndrome.
• Blood transfusions for anemia.
• Symptomatic treatment for fatigue and weakness.

Infection Control:

• Standard precautions to prevent infections in immunocompromised patients.

How to Document Symptoms of Waldenstrom macroglobulinemia (ICD-10 C88.0) in SOAP Notes

Subjective:

• Patient reports fatigue and unintentional weight loss over the past few months.
• Complaints of headaches and occasional blurred vision.
• History of recurrent infections.

Objective:

• Elevated serum IgM levels noted in lab results.
• Physical examination reveals splenomegaly.
• Complete blood count shows anemia and thrombocytopenia.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Waldenstrom macroglobulinemia (ICD-10 Code C88.0)

Assessment:

• Diagnosis: Waldenstrom macroglobulinemia, moderate severity.
• ICD-10 Code: C88.0.
• Contributing factors include elevated IgM levels and splenomegaly.

Plan:

• Initiate chemotherapy regimen tailored for Waldenstrom macroglobulinemia.
• Consider plasmapheresis for symptomatic hyperviscosity.
• Schedule follow-up appointments for monitoring IgM levels and overall health.

Treatment & Plan Section for ICD-10 Code C88.0 – Waldenstrom macroglobulinemia

• First-line treatment includes chemotherapy agents such as bendamustine or rituximab.
• Non-pharmacologic strategies include nutritional support and physical therapy.
• Monitoring of serum IgM levels and complete blood counts regularly.
• Follow-up visits every 1-3 months to assess treatment response.

Using ICD-10 Code C88.0 for Waldenstrom macroglobulinemia in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in Subjective (S) and Objective (O) sections.
• Use C88.0 in billing to reflect the diagnosis and support treatment claims.
• Align treatment plans with clinical guidelines to justify billing.
• Document any complications or comorbidities that may affect treatment.

Related ICD-10 Codes Often Used with Waldenstrom macroglobulinemia

ICD-10 Code C88.0 in Medical Billing and Insurance for Waldenstrom macroglobulinemia

ICD-10 Code C88.0 is critical for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
• Use C88.0 in conjunction with other codes for comorbid conditions.
• Ensure that the diagnosis is clearly linked to the services provided in the medical record.

Common CPT Pairings: